Swiss Re’s Amgen AMGN Stock Holding History

Swiss Re’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$543K	Buy	1,289 +505	+64%	+$201K	0.29%	66
2026 Q2	$284K	Buy	784 +740	+1,682%	+$253K	0.03%	79
2026 Q1	$15.5K	Hold	44	–	–	0.09%	166
2025 Q4	$14.4K	Buy	+44	New	+$14K	﹤0.01%	175

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Swiss Re's AMGN Position: Q3 2026 in Review

Swiss Re increased its Amgen (AMGN) stake by 64% in Q3 2026, buying an estimated $201K and bringing the position to 1,289 shares worth $543K. The position accounts for 0.29% of the portfolio, ranked #66.

Swiss Re first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Swiss Re held 1,289 shares of Amgen worth $543K as of Q3 2026.
Swiss Re bought 505 Amgen shares in Q3 2026, an estimated $201K.
Amgen made up 0.29% of Swiss Re's portfolio in Q3 2026, its #66 holding.
Swiss Re first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Swiss Re's 13F filing for Q3 2026, filed 6 Nov 2026.